News & Media

News and Media

Our News

COVID-19: HTL is protecting the safety of its employees and its facility

March 2020

HTL is protecting the safety of its employees and its facility, in order to guarantee supply chain continuity for its clients. Click here to view the statement. Cliquez ici pour visualiser le point de situation.

We will update this status report as the situation develops. The HTL team is available to answer your questions or provide further information.

HTL is exhibiting at 22nd IMCAS World Congress

January 2020

HTL works with its clients in the aesthetics sector to take dermal filling and skin rejuvenation to the next level. HTL is exhibiting at the 22nd World Congress IMCAS 2020 in Paris. The International Master Course in Aging Science addresses Youth & Age in dermatology, plastic surgery and aesthetic science.

HTL invests in GMP manufacturing capacity to support the rapidly growing market of Hyaluronic Acid Medical Applications

October 2019

HTL invests in GMP manufacturing capacity to support the rapidly growing market of Hyaluronic Acid Medical Applications. HTL announces its investment in a state-of-the-art production facility that will multiply its injectable grade sodium hyaluronate production capacity by 2.5 by 2021. This new capacity represents a much-needed opening in a global market under high pressure.

HTL at CPhI Worldwide 2019

October 2019

As an API manufacturer, HTL will be exhibiting at the CPhI Worldwide exhibition in Frankfurt, from 5 to 7 November 2019 at stand 42G13 (Hall 4.2). Our team will be available to discuss value creation opportunities with biopolymers in the fields of dermatology, ophthalmology, rheumatology, along with urology, oncology, biomaterials and regenerative medicine. Stop by and come discuss your needs. We look forward to introducing you to our:

  • Hyaluronic Acid (Sodium Hyaluronate) of non-animal, natural origin, matching your specific demands
  • New GlycosAminoGlycans: Heparosan and Chondroitin
  • Functionalized derivatives of GlycosAminoGlycans, bringing new functionalities to your end products: improved stability, mechanical and biological properties

Come and join us at this leading show!

Press Release: HTL invests in GMP manufacturing capacity

October 2019

HTL invests in GMP manufacturing capacity to support the rapidly growing market of hyaluronic acid medical applications. Read more below.

English | Français